Solid Biosciences Announces Stockholder Approval Of Acquisition Of Aavantibio
Acquiring Company
Solid Biosciences
Acquired Company
AavantiBio, Inc.
CharlestownGainesvilleBiotechnologyHealthcareHealth CareGeneticsTherapeuticsBiotechnologyHealth CareGeneticsTherapeuticsDescription
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the results of the special meeting of the stockholders held on December 1, 2022. At the special meeting, Solid’s stockholders voted in favor of all proposals, including the proposal to issue shares of Solid’s common stock to stockholders of AavantiBio in connection with the acquisition of AavantiBio pursuant to the agreement and plan of merger dated September 29, 2022 (the “Merger Agreement”) and to certain institutional investors in connection with a concurrent $75 million private placement. AavantiBio, Inc. is a privately held gene therapy company focused on transforming the lives of patients with Friedreich’s ataxia and rare cardiomyopathies.
Quick answer
Solid Biosciences is acquiring AavantiBio, Inc., announced December 1, 2022. Solid Biosciences is based in Charlestown, Massachusetts, United States.
- Who acquired AavantiBio, Inc?
- Solid Biosciences agreed to acquire AavantiBio, Inc. on December 1, 2022.
- How much did Solid Biosciences pay for AavantiBio, Inc?
- The deal value was not disclosed.
- What does Solid Biosciences do?
- Solid Biosciences is a life sciences company focused on advancing a portfolio of gene therapy candidates and neuromuscular and cardiac programs, including SGT-003, for the treatment of Duchenne muscular dystrophy..
- Where are Solid Biosciences and AavantiBio, Inc. based?
- Solid Biosciences is based in Charlestown, Massachusetts, United States. AavantiBio, Inc. is based in Gainesville, Florida, United States.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Genetics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Solid Biosciences Announces Closing Of Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (December 5, 2022)
- Rocket Pharmaceuticals Completes Acquisition Of Renovacor (December 1, 2022)
- Merck Completes Tender Offer To Acquire Imago Biosciences, Inc. (January 11, 2023)
- Merck To Acquire Imago Biosciences, Inc. (November 21, 2022)
- Prenetics Acquires Act Genomics, Creating A Leader In Comprehensive Cancer Genetics And Precision Oncology (December 16, 2022)
- Lilly Completes Acquisition Of Akouos Expanding Efforts To Help People With Genetic Diseases (December 1, 2022)
Who to call at Solid Biosciences, and when
When Solid Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Solid Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Solid Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Solid Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Solid Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired AavantiBio, Inc.?
AavantiBio, Inc. was acquired by Solid Biosciences, based in Charlestown. The deal was reported on December 1, 2022. Solid Biosciences is publicly traded (SLDB) and operates in Biotechnology.
When did Solid Biosciences acquire AavantiBio, Inc.?
Solid Biosciences's acquisition of AavantiBio, Inc. was reported on December 1, 2022. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the results of the special meeting of the stockholders held on December 1, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AavantiBio, Inc. do?
It is privately held, operating in Biotechnology, and is based in Gainesville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.